Corporate Profile

LabCorp (NYSE: LH), an S&P 500 company, is a leading global life sciences company that is deeply integrated in guiding patient care, providing comprehensive clinical laboratory and end-to-end drug development services. With a mission to improve health and improve lives, LabCorp delivers world-class diagnostic solutions, brings innovative medicines to patients faster and uses technology to improve the delivery of care. LabCorp reported net revenues of nearly $9.5 billion ... Read More >>

Recent News

02/06/18

LabCorp Announces Record 2017 Fourth Quarter and Full Year Results and Provides 2018 Guidance

01/19/18

LabCorp Named to FORTUNE Magazine's 2018 List of ‘World’s Most Admired Companies’

01/08/18

Covance Introduces Dedicated Offering Designed for Biotech, Medical Device and Diagnostics Companies

Upcoming Events

Tuesday, February 27, 2018

LabCorp Investor & Analyst Day, New York, NY

LH (Common)
ExchangeNYSE
Price$177.79
Change Stock is Up 3.83
Data as of 02/16/18 4:02 p.m. ET
Refresh quote
Data provided by Nasdaq. Minimum 15 minutes delayed.
Print Page Print Page | E-mail Page E-mail Page | RSS Feeds RSS Feeds | E-mail Alerts E-mail Alerts | IR Contacts IR Contacts | Financial Tear Sheet Tear Sheet